Ticker Scorecard - SWTX Basics Company: SpringWorks Therapeutics, Inc. IPO Date: September 19, 2019 Sector: Healthcare Industry: Biotech Market Cap: $4.37B Activated in VL: True Average Daily Range Avg Daily Range: $1.32 | 3.14% Avg Daily Range (30 D): $1.77 | 4.34% Avg Daily Range (90 D): $1.13 | 2.99% Institutional Daily Volume Avg Daily Volume: .54M Avg Daily Volume (30 D): 2.62M Avg Daily Volume (90 D): 1.49M Trade Size Avg Trade Size (Sh.): 65 Avg Trade Size (Sh.) (30 D): 86 Avg Trade Size (Sh.) (90 D): 77 Institutional Trades Total Inst.Trades: 3,105 Avg Inst. Trade: $2.55M Avg Inst. Trade (30 D): $2.62M Avg Inst. Trade (90 D): $2.95M Avg Inst. Trade Volume: .07M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.98M Avg Closing Trade (30 D): $7.93M Avg Closing Trade (90 D): $6.27M Avg Closing Volume: 105.37K     News Feb 17, 2025 @ 9:05 PM Onco360 Has Been Selected as a National Specialty ... Source: N/A Feb 12, 2025 @ 1:20 AM UPDATE: SpringWorks Therapeutics Announces FDA App... Source: N/A Feb 11, 2025 @ 4:41 PM Germany's Merck In Talks To Buy Cancer Drug Maker ... Source: Benzinga Editor Dec 19, 2024 @ 6:00 PM Comprehensive Market Analysis of Latest Published ... Source: Delveinsight Nov 26, 2024 @ 12:00 PM SpringWorks Therapeutics to Participate in the 7th... Source: N/A Financials   TTM Q4 2024 FY 2024 Basic EPS $-3.48 $-1.04 $-3.48 Diluted EPS $-3.48 $-1.04 $-3.48 Revenue $ 191.59M $ 61.55M $ 191.59M Gross Profit $ 179.04M $ 56M $ 179.04M Net Income / Loss $ -258.13M $ -77.3M $ -258.13M Operating Income / Loss $ -278.13M $ -81.34M $ -278.13M Cost of Revenue $ 12.55M $ 5.55M $ 12.55M Net Cash Flow $ -106.29M $ -14.7M $ -106.29M PE Ratio     Splits Mar 17, 2011:   5:1